Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005829 | cytosol | 2 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HK70
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 12 |
GO:0006644 | phospholipid metabolic process | 4 | 12 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 6 | 12 |
GO:0006650 | glycerophospholipid metabolic process | 5 | 12 |
GO:0006793 | phosphorus metabolic process | 3 | 12 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0008610 | lipid biosynthetic process | 4 | 12 |
GO:0008654 | phospholipid biosynthetic process | 5 | 12 |
GO:0009058 | biosynthetic process | 2 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0019637 | organophosphate metabolic process | 3 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0044249 | cellular biosynthetic process | 3 | 12 |
GO:0044255 | cellular lipid metabolic process | 3 | 12 |
GO:0045017 | glycerolipid biosynthetic process | 4 | 12 |
GO:0046337 | phosphatidylethanolamine metabolic process | 6 | 12 |
GO:0046474 | glycerophospholipid biosynthetic process | 5 | 12 |
GO:0046486 | glycerolipid metabolic process | 4 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0090407 | organophosphate biosynthetic process | 4 | 12 |
GO:1901576 | organic substance biosynthetic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity | 6 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 12 |
GO:0016779 | nucleotidyltransferase activity | 4 | 12 |
GO:0070567 | cytidylyltransferase activity | 5 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 157 | 161 | PF00656 | 0.418 |
CLV_C14_Caspase3-7 | 391 | 395 | PF00656 | 0.399 |
CLV_NRD_NRD_1 | 216 | 218 | PF00675 | 0.366 |
CLV_NRD_NRD_1 | 252 | 254 | PF00675 | 0.263 |
CLV_NRD_NRD_1 | 75 | 77 | PF00675 | 0.308 |
CLV_PCSK_KEX2_1 | 132 | 134 | PF00082 | 0.227 |
CLV_PCSK_KEX2_1 | 168 | 170 | PF00082 | 0.207 |
CLV_PCSK_KEX2_1 | 376 | 378 | PF00082 | 0.450 |
CLV_PCSK_KEX2_1 | 381 | 383 | PF00082 | 0.494 |
CLV_PCSK_KEX2_1 | 75 | 77 | PF00082 | 0.308 |
CLV_PCSK_PC1ET2_1 | 132 | 134 | PF00082 | 0.227 |
CLV_PCSK_PC1ET2_1 | 168 | 170 | PF00082 | 0.218 |
CLV_PCSK_PC1ET2_1 | 376 | 378 | PF00082 | 0.471 |
CLV_PCSK_PC1ET2_1 | 381 | 383 | PF00082 | 0.501 |
CLV_PCSK_PC7_1 | 377 | 383 | PF00082 | 0.403 |
CLV_PCSK_SKI1_1 | 129 | 133 | PF00082 | 0.318 |
CLV_PCSK_SKI1_1 | 165 | 169 | PF00082 | 0.215 |
CLV_PCSK_SKI1_1 | 181 | 185 | PF00082 | 0.282 |
CLV_PCSK_SKI1_1 | 371 | 375 | PF00082 | 0.447 |
CLV_PCSK_SKI1_1 | 377 | 381 | PF00082 | 0.539 |
CLV_Separin_Metazoa | 90 | 94 | PF03568 | 0.511 |
DEG_SCF_TRCP1_1 | 353 | 359 | PF00400 | 0.364 |
DEG_SPOP_SBC_1 | 4 | 8 | PF00917 | 0.651 |
DOC_ANK_TNKS_1 | 52 | 59 | PF00023 | 0.273 |
DOC_CYCLIN_RxL_1 | 178 | 188 | PF00134 | 0.488 |
DOC_CYCLIN_yClb1_LxF_4 | 369 | 374 | PF00134 | 0.430 |
DOC_MAPK_gen_1 | 276 | 285 | PF00069 | 0.474 |
DOC_MAPK_gen_1 | 75 | 83 | PF00069 | 0.508 |
DOC_MAPK_MEF2A_6 | 47 | 56 | PF00069 | 0.304 |
DOC_PP1_RVXF_1 | 216 | 223 | PF00149 | 0.421 |
DOC_PP1_RVXF_1 | 369 | 375 | PF00149 | 0.455 |
DOC_PP4_FxxP_1 | 94 | 97 | PF00568 | 0.511 |
DOC_SPAK_OSR1_1 | 133 | 137 | PF12202 | 0.422 |
DOC_USP7_MATH_1 | 3 | 7 | PF00917 | 0.619 |
DOC_USP7_MATH_1 | 334 | 338 | PF00917 | 0.450 |
DOC_USP7_UBL2_3 | 376 | 380 | PF12436 | 0.484 |
DOC_WW_Pin1_4 | 12 | 17 | PF00397 | 0.534 |
DOC_WW_Pin1_4 | 224 | 229 | PF00397 | 0.450 |
DOC_WW_Pin1_4 | 6 | 11 | PF00397 | 0.612 |
LIG_Actin_WH2_2 | 176 | 194 | PF00022 | 0.543 |
LIG_Actin_WH2_2 | 239 | 255 | PF00022 | 0.367 |
LIG_Actin_WH2_2 | 56 | 74 | PF00022 | 0.418 |
LIG_APCC_ABBA_1 | 264 | 269 | PF00400 | 0.388 |
LIG_APCC_ABBA_1 | 346 | 351 | PF00400 | 0.427 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.452 |
LIG_FHA_1 | 15 | 21 | PF00498 | 0.428 |
LIG_FHA_1 | 168 | 174 | PF00498 | 0.424 |
LIG_FHA_1 | 358 | 364 | PF00498 | 0.315 |
LIG_FHA_1 | 39 | 45 | PF00498 | 0.364 |
LIG_FHA_1 | 49 | 55 | PF00498 | 0.295 |
LIG_FHA_2 | 336 | 342 | PF00498 | 0.442 |
LIG_LIR_Apic_2 | 337 | 343 | PF02991 | 0.353 |
LIG_LIR_Gen_1 | 103 | 111 | PF02991 | 0.464 |
LIG_LIR_Gen_1 | 154 | 161 | PF02991 | 0.407 |
LIG_LIR_Gen_1 | 238 | 249 | PF02991 | 0.407 |
LIG_LIR_Gen_1 | 260 | 267 | PF02991 | 0.500 |
LIG_LIR_Gen_1 | 34 | 44 | PF02991 | 0.388 |
LIG_LIR_Gen_1 | 57 | 68 | PF02991 | 0.407 |
LIG_LIR_Nem_3 | 103 | 109 | PF02991 | 0.415 |
LIG_LIR_Nem_3 | 154 | 158 | PF02991 | 0.407 |
LIG_LIR_Nem_3 | 238 | 244 | PF02991 | 0.407 |
LIG_LIR_Nem_3 | 260 | 264 | PF02991 | 0.442 |
LIG_LIR_Nem_3 | 34 | 39 | PF02991 | 0.331 |
LIG_LIR_Nem_3 | 394 | 399 | PF02991 | 0.520 |
LIG_LIR_Nem_3 | 57 | 63 | PF02991 | 0.414 |
LIG_LYPXL_yS_3 | 280 | 283 | PF13949 | 0.474 |
LIG_OCRL_FandH_1 | 59 | 71 | PF00620 | 0.407 |
LIG_PCNA_yPIPBox_3 | 286 | 296 | PF02747 | 0.418 |
LIG_PTB_Apo_2 | 118 | 125 | PF02174 | 0.449 |
LIG_PTB_Apo_2 | 198 | 205 | PF02174 | 0.330 |
LIG_PTB_Phospho_1 | 118 | 124 | PF10480 | 0.449 |
LIG_Rb_LxCxE_1 | 34 | 51 | PF01857 | 0.393 |
LIG_SH2_PTP2 | 261 | 264 | PF00017 | 0.352 |
LIG_SH2_SRC | 155 | 158 | PF00017 | 0.418 |
LIG_SH2_SRC | 236 | 239 | PF00017 | 0.407 |
LIG_SH2_SRC | 261 | 264 | PF00017 | 0.407 |
LIG_SH2_STAP1 | 267 | 271 | PF00017 | 0.511 |
LIG_SH2_STAT3 | 267 | 270 | PF00017 | 0.453 |
LIG_SH2_STAT5 | 117 | 120 | PF00017 | 0.421 |
LIG_SH2_STAT5 | 124 | 127 | PF00017 | 0.395 |
LIG_SH2_STAT5 | 138 | 141 | PF00017 | 0.407 |
LIG_SH2_STAT5 | 236 | 239 | PF00017 | 0.407 |
LIG_SH2_STAT5 | 261 | 264 | PF00017 | 0.407 |
LIG_SH2_STAT5 | 297 | 300 | PF00017 | 0.426 |
LIG_SH3_3 | 10 | 16 | PF00018 | 0.612 |
LIG_SH3_3 | 43 | 49 | PF00018 | 0.363 |
LIG_SUMO_SIM_par_1 | 14 | 22 | PF11976 | 0.340 |
LIG_TRAF2_1 | 154 | 157 | PF00917 | 0.418 |
LIG_TRAF2_1 | 87 | 90 | PF00917 | 0.431 |
MOD_CDK_SPK_2 | 224 | 229 | PF00069 | 0.459 |
MOD_CK1_1 | 223 | 229 | PF00069 | 0.455 |
MOD_CK1_1 | 354 | 360 | PF00069 | 0.381 |
MOD_CK1_1 | 388 | 394 | PF00069 | 0.388 |
MOD_CK1_1 | 6 | 12 | PF00069 | 0.660 |
MOD_CK2_1 | 151 | 157 | PF00069 | 0.418 |
MOD_CK2_1 | 190 | 196 | PF00069 | 0.513 |
MOD_CK2_1 | 325 | 331 | PF00069 | 0.518 |
MOD_CK2_1 | 335 | 341 | PF00069 | 0.459 |
MOD_CK2_1 | 84 | 90 | PF00069 | 0.407 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.492 |
MOD_GlcNHglycan | 21 | 24 | PF01048 | 0.465 |
MOD_GlcNHglycan | 229 | 232 | PF01048 | 0.408 |
MOD_GlcNHglycan | 353 | 356 | PF01048 | 0.339 |
MOD_GSK3_1 | 167 | 174 | PF00069 | 0.424 |
MOD_GSK3_1 | 220 | 227 | PF00069 | 0.477 |
MOD_GSK3_1 | 4 | 11 | PF00069 | 0.619 |
MOD_N-GLC_1 | 151 | 156 | PF02516 | 0.152 |
MOD_N-GLC_1 | 223 | 228 | PF02516 | 0.420 |
MOD_NEK2_1 | 213 | 218 | PF00069 | 0.303 |
MOD_NEK2_2 | 291 | 296 | PF00069 | 0.418 |
MOD_PIKK_1 | 385 | 391 | PF00454 | 0.518 |
MOD_PKA_2 | 325 | 331 | PF00069 | 0.531 |
MOD_Plk_1 | 143 | 149 | PF00069 | 0.407 |
MOD_Plk_1 | 151 | 157 | PF00069 | 0.407 |
MOD_Plk_2-3 | 143 | 149 | PF00069 | 0.418 |
MOD_Plk_4 | 359 | 365 | PF00069 | 0.487 |
MOD_ProDKin_1 | 224 | 230 | PF00069 | 0.454 |
MOD_ProDKin_1 | 6 | 12 | PF00069 | 0.612 |
MOD_SUMO_rev_2 | 200 | 209 | PF00179 | 0.478 |
MOD_SUMO_rev_2 | 385 | 393 | PF00179 | 0.521 |
TRG_ENDOCYTIC_2 | 106 | 109 | PF00928 | 0.407 |
TRG_ENDOCYTIC_2 | 155 | 158 | PF00928 | 0.407 |
TRG_ENDOCYTIC_2 | 261 | 264 | PF00928 | 0.374 |
TRG_ENDOCYTIC_2 | 280 | 283 | PF00928 | 0.474 |
TRG_ENDOCYTIC_2 | 349 | 352 | PF00928 | 0.417 |
TRG_ENDOCYTIC_2 | 36 | 39 | PF00928 | 0.395 |
TRG_ER_diArg_1 | 75 | 77 | PF00400 | 0.508 |
TRG_NES_CRM1_1 | 188 | 200 | PF08389 | 0.339 |
TRG_NLS_MonoExtC_3 | 379 | 384 | PF00514 | 0.346 |
TRG_NLS_MonoExtN_4 | 377 | 384 | PF00514 | 0.332 |
TRG_Pf-PMV_PEXEL_1 | 217 | 221 | PF00026 | 0.346 |
TRG_Pf-PMV_PEXEL_1 | 256 | 260 | PF00026 | 0.249 |
TRG_Pf-PMV_PEXEL_1 | 75 | 80 | PF00026 | 0.311 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P9A3 | Leptomonas seymouri | 80% | 100% |
A0A0S4KIJ8 | Bodo saltans | 68% | 97% |
A0A1X0NUM2 | Trypanosomatidae | 68% | 100% |
A0A3S7X5B3 | Leishmania donovani | 88% | 100% |
A0A422N8Y0 | Trypanosoma rangeli | 65% | 100% |
A4I7Q5 | Leishmania infantum | 88% | 100% |
A9N9S2 | Coxiella burnetii (strain RSA 331 / Henzerling II) | 25% | 85% |
D0A9W0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 61% | 100% |
E9B2L3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
O88637 | Rattus norvegicus | 43% | 100% |
P33412 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 34% | 100% |
Q4Q5J3 | Leishmania major | 85% | 100% |
Q55BZ4 | Dictyostelium discoideum | 54% | 100% |
Q5EA75 | Bos taurus | 46% | 100% |
Q83B60 | Coxiella burnetii (strain RSA 493 / Nine Mile phase I) | 25% | 85% |
Q8SQW6 | Encephalitozoon cuniculi (strain GB-M1) | 37% | 100% |
Q922E4 | Mus musculus | 43% | 100% |
Q99447 | Homo sapiens | 44% | 100% |
Q9UTI6 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 33% | 100% |
Q9ZVI9 | Arabidopsis thaliana | 44% | 96% |
V5DHH9 | Trypanosoma cruzi | 64% | 100% |